244 related articles for article (PubMed ID: 6499112)
1. 32P-post-labelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally-occurring alkenylbenzenes. I. Adult female CD-1 mice.
Randerath K; Haglund RE; Phillips DH; Reddy MV
Carcinogenesis; 1984 Dec; 5(12):1613-22. PubMed ID: 6499112
[TBL] [Abstract][Full Text] [Related]
2. 32P-post-labelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally-occurring alkenylbenzenes. II. Newborn male B6C3F1 mice.
Phillips DH; Reddy MV; Randerath K
Carcinogenesis; 1984 Dec; 5(12):1623-8. PubMed ID: 6499113
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity studies of the carcinogenicities in the mouse and rat of some naturally occurring and synthetic alkenylbenzene derivatives related to safrole and estragole.
Miller EC; Swanson AB; Phillips DH; Fletcher TL; Liem A; Miller JA
Cancer Res; 1983 Mar; 43(3):1124-34. PubMed ID: 6825084
[TBL] [Abstract][Full Text] [Related]
4. Further characterization of the DNA adducts formed by electrophilic esters of the hepatocarcinogens 1'-hydroxysafrole and 1'-hydroxyestragole in vitro and in mouse liver in vivo, including new adducts at C-8 and N-7 of guanine residues.
Wiseman RW; Fennell TR; Miller JA; Miller EC
Cancer Res; 1985 Jul; 45(7):3096-105. PubMed ID: 4005847
[TBL] [Abstract][Full Text] [Related]
5. DNA adducts from alkoxyallylbenzene herb and spice constituents in cultured human (HepG2) cells.
Zhou GD; Moorthy B; Bi J; Donnelly KC; Randerath K
Environ Mol Mutagen; 2007 Dec; 48(9):715-21. PubMed ID: 17948277
[TBL] [Abstract][Full Text] [Related]
6. The metabolic activation and nucleic acid adducts of naturally-occurring carcinogens: recent results with ethyl carbamate and the spice flavors safrole and estragole.
Miller JA; Miller EC
Br J Cancer; 1983 Jul; 48(1):1-15. PubMed ID: 6191767
[TBL] [Abstract][Full Text] [Related]
7. The side-chain epoxidation and hydroxylation of the hepatocarcinogens safrole and estragole and some related compounds by rat and mouse liver microsomes.
Swanson AB; Miller EC; Miller JA
Biochim Biophys Acta; 1981 Apr; 673(4):504-16. PubMed ID: 7225430
[TBL] [Abstract][Full Text] [Related]
8. Use of the 32P-postlabelling assay to study transplacental carcinogens and transplacental carcinogenesis.
Randerath K; Liehr JG; Gladek A; Randerath E
IARC Sci Publ; 1989; (96):189-205. PubMed ID: 2509347
[TBL] [Abstract][Full Text] [Related]
9. Formation and persistence of safrole-DNA adducts over a 10,000-fold dose range in mouse liver.
Gupta KP; van Golen KL; Putman KL; Randerath K
Carcinogenesis; 1993 Aug; 14(8):1517-21. PubMed ID: 8102595
[TBL] [Abstract][Full Text] [Related]
10. Major role of hepatic sulfotransferase activity in the metabolic activation, DNA adduct formation, and carcinogenicity of 1'-hydroxy-2',3'-dehydroestragole in infant male C57BL/6J x C3H/HeJ F1 mice.
Fennell TR; Wiseman RW; Miller JA; Miller EC
Cancer Res; 1985 Nov; 45(11 Pt 1):5310-20. PubMed ID: 3863702
[TBL] [Abstract][Full Text] [Related]
11. 32P-postlabeling assay in mice of transplacental DNA damage induced by the environmental carcinogens safrole, 4-aminobiphenyl, and benzo(a)pyrene.
Lu LJ; Disher RM; Reddy MV; Randerath K
Cancer Res; 1986 Jun; 46(6):3046-54. PubMed ID: 3698023
[TBL] [Abstract][Full Text] [Related]
12. N2 atom of guanine and N6 atom of adenine residues as sites for covalent binding of metabolically activated 1'-hydroxysafrole to mouse liver DNA in vivo.
Phillips DH; Miller JA; Miller EC; Adams B
Cancer Res; 1981 Jul; 41(7):2664-71. PubMed ID: 7248936
[TBL] [Abstract][Full Text] [Related]
13. Strong evidence from studies with brachymorphic mice and pentachlorophenol that 1'-sulfoöxysafrole is the major ultimate electrophilic and carcinogenic metabolite of 1'-hydroxysafrole in mouse liver.
Boberg EW; Miller EC; Miller JA; Poland A; Liem A
Cancer Res; 1983 Nov; 43(11):5163-73. PubMed ID: 6577945
[TBL] [Abstract][Full Text] [Related]
14. Identification and quantitation of hepatic DNA adducts formed in B6C3F1 mice from 1'-hydroxy-2',3'-dehydroestragole: comparison of the adducts detected with the 1'-3H-labelled carcinogen and by 32P-postlabelling.
Fennell TR; Juhl U; Miller EC; Miller JA
Carcinogenesis; 1986 Nov; 7(11):1881-7. PubMed ID: 3769137
[TBL] [Abstract][Full Text] [Related]
15. 32P-postlabeling analysis of adducts formed between DNA and safrole 2',3'-epoxide: absence of adduct formation in vivo.
Qato MK; Guenthner TM
Toxicol Lett; 1995 Jan; 75(1-3):201-7. PubMed ID: 7863528
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity studies of the hepatocarcinogenicities of alkenylbenzene derivatives related to estragole and safrole on administration to preweanling male C57BL/6J x C3H/HeJ F1 mice.
Wiseman RW; Miller EC; Miller JA; Liem A
Cancer Res; 1987 May; 47(9):2275-83. PubMed ID: 3567921
[TBL] [Abstract][Full Text] [Related]
17. Comparative induction of unscheduled DNA synthesis in cultured rat hepatocytes by allylbenzenes and their 1'-hydroxy metabolites.
Chan VS; Caldwell J
Food Chem Toxicol; 1992 Oct; 30(10):831-6. PubMed ID: 1427504
[TBL] [Abstract][Full Text] [Related]
18. Tamoxifen: evidence by 32P-postlabeling and use of metabolic inhibitors for two distinct pathways leading to mouse hepatic DNA adduct formation and identification of 4-hydroxytamoxifen as a proximate metabolite.
Randerath K; Moorthy B; Mabon N; Sriram P
Carcinogenesis; 1994 Oct; 15(10):2087-94. PubMed ID: 7955037
[TBL] [Abstract][Full Text] [Related]
19. Physiologically based biokinetic (PBBK) model for safrole bioactivation and detoxification in rats.
Martati E; Boersma MG; Spenkelink A; Khadka DB; Punt A; Vervoort J; van Bladeren PJ; Rietjens IM
Chem Res Toxicol; 2011 Jun; 24(6):818-34. PubMed ID: 21446753
[TBL] [Abstract][Full Text] [Related]
20. The metabolic activation of the carcinogen 1'-hydroxysafrole in vivo and in vitro and the electrophilic reactivities of possible ultimate carcinogens.
Wislocki PG; Borchert P; Miller JA; Miller EC
Cancer Res; 1976 May; 36(5):1686-95. PubMed ID: 5188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
